Home » Topics » BioWorld Science

BioWorld Science
RSS

Arcus Biosciences divulges ARG1 and ARG2 inhibitors

Sep. 30, 2019

Phase IIa data support S-600918 as promising option for refractory chronic cough

Sep. 30, 2019

Zoliflodacin begins pivotal phase III trial for treatment of gonorrhea

Sep. 30, 2019

ESMO 2019: Immunity is local phenomenon, for better and for worse

Sep. 30, 2019

WX-0593 shows antitumor activity in ALK/ROS1-positive NSCLC

Sep. 30, 2019

Emergent BioSolutions, Indivior win NIH grants to study drugs for opioid use disorder

Sep. 30, 2019

Antithrombin isoform protects against sepsis

Sep. 30, 2019

Phase I data presented on ADCT-601 in patients with advanced solid tumors

Sep. 30, 2019

Anchoring protein is potential biomarker, target for Parkinson's disease

Sep. 30, 2019

Second phase III trial of AVP-786 for agitation in Alzheimer's dementia misses endpoints

Sep. 30, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
Research grants support early clinical trials of ALS treatments
BioWorld Science
The ALS Association has announced the recipients of its 2025 Hoffman ALS Clinical Trial Awards. These research grants, worth up to $1 million each, support...